• Mashup Score: 0
    TRIANGLE Trial Results Support First-Line Ibrutinib Use in MCL - 9 month(s) ago

    High-dose cytarabine-containing immunochemotherapy followed by autologous hematopoiet ic stem cell transplantation (AHSCT) “failed to show superiority over” an ibrutinib-containing treatment without AHSCT in patients with mantle cell lymphoma, according to results from the phase III TRIANGLE trial. Martin Dreyling, MD, of the LMU University Hospital Munich in Germany, and colleagues conducted the study and presented its results at the 2022 American Society of Hematology Annual Meeting. The European MCL

    Source: bloodcancerstoday.com
    Categories: Latest Headlines, Partners & KOLs
    Tweet Tweets with this article
    • Profile photo of Blood_Cancers
      Blood_Cancers

      Need a refresher on the TRIANGLE study? Check out our coverage from #ASH22: https://t.co/ol6Nrfj7OK https://t.co/YFxGbrmIA6

  • Mashup Score: 0
    2023 ASH CLL Update [Slides] - Elizabeth Brem- MOASC zanubrutinib - 9 month(s) ago

    Zanubrutinib compared to ibrutinib in chronic lymphocytic leukemia So I’m gonna start with chronic lymphocytic leukemia. And as part of late-breaking abstracts, we got this study which was zanubrutinib compared to ibrutinib before chronic lymphocytic leukemia.Relatively straightforward study design. These were previ…

    Source: oncologytube.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of oncologytube
      oncologytube

      📣 Elizabeth Brem, MD @DrLizBrem compares #Zanubrutinib to #ibutrinib for #CLL patients w [Slides] [video] https://t.co/hh4TiIlKdn @UCIrvineHealth @MOASC_Office #ASH22 #MOASC23 #Lymphoma #leusm #Oncology https://t.co/Z2jGfStLs8

  • Mashup Score: 0
    2023 ASH Etavopivat Update [Slides] - Zahra Pakbaz MD MOASC - 9 month(s) ago

    2023 ASH Pregnancy Update Slides Etavopivat treatment Low molecular weight heparin versus a standard pregnancy care for women with recurrent miscarriage Okay, so this first abstract let’s talk about low molecular weight heparin versus a standard pregnancy care for women with recurrent miscarriage age and inherited t…

    Source: oncologytube.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of oncologytube
      oncologytube

      🔬Join Dr. Pakbaz @ucihealth @UCIrvineCCR @MOASC_Office for a deep dive w [Slides] [video] https://t.co/LPbHbiSnnu on hematology and pregnancy from #ASH22 discussing #Etavopivat, @ALIFE2trial #ALIFE2, and #heparin. 📊💡#LMWH #pregnancy #recurrent #miscarriage @MiddeldorpS https://t.co/IM1JHa0rVH

  • Mashup Score: 0
    Webprogram Unavailable - 11 month(s) ago

    Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.

    Source: ash.confex.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Novel Associations between Clonal Hematopoiesis [CH] and Therapeutic Exposures Revealed in Patients with Solid Tumors Using Real World Evidence [Sat, Dec 10, 2022, 5:30-7:30p] Sonnenschein et al. @TempusLabs Abstract 1227 #ASH22 https://t.co/znqsANDINM

  • Mashup Score: 0
    Webprogram Unavailable - 11 month(s) ago

    Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.

    Source: ash.confex.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study [Dec 10, 2022] @NoemiPuigM et al. @BerdejaJesus Abs 1859 #ASH22 https://t.co/mCCkPgMebV #mmsm #globonc https://t.co/SbV7lfv3tJ

  • Mashup Score: 0
    Webprogram Unavailable - 11 month(s) ago

    Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.

    Source: ash.confex.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      BMT w/in 4 wks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study [Sat, Dec 10, 2022] @MeeraMohanMD Abst 387 #ASH22 https://t.co/4MtPzSAUAs #COVID19nCancer #bmtsm #IDonc #COVID19 #AMLsm #leusm OR 49.6 https://t.co/YKZ1zWwMgF

  • Mashup Score: 1
    Program Guide – ASCO Meeting Program Guide - 11 month(s) ago

    AuthorsJuan DuShanghai Changzheng Hospital, Shanghai, Shanghai, ChinaJuan Du, Wei-Jun Fu, Hua Jiang, Baoxia Dong, Li Gao, Li Liu, Jian Ge, Aili He, Lu Li, Jing Lu, Xiequn Chen, Jia Liu, Qi Zhang, Jiaping He, Lianjun Shen, Lihong Weng, Hua Zhang, Wei Cao, Wenling LiOrganizationsShanghai Changzheng Hospital, Shanghai, Shanghai, China, Shanghai Changzheng Hospital, Shanghai, China, Xijing Hospital,…

    Source: meetings.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HadidiSamer
      HadidiSamer

      #mmsm #ASCO23 BCMA/CD19 dual-targeting CAR-T ➡️ https://t.co/IGPKsiG4GS 🛑presented #ASCO22 #ASH22 ✅continue to show some promise with high ORR , MRD-ve but I am concerned about presenting this every few months with few more pts(n=29) ✅median: DOR:37 mo,PFS:38 mo https://t.co/KmFARjgjdp

  • Mashup Score: 1
    Webprogram Unavailable - 11 month(s) ago

    Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.

    Source: ash.confex.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study [Dec 10, 2022] @NoemiPuigM et al. @BerdejaJesus Abs 1859 #ASH22 https://t.co/mCCkPgMebV #mmsm #globonc https://t.co/uDpGCoIm73

Load More